Chronic administration of aluminum-fluoride or sodium-fluoride to rats in drinking water: Alterations in neuronal and cerebrovascular integrity

Brain Research

Volumn 784, Issue 1-2, 1998, Pages 284-298

  Varner, Julie A ^a   Jensen, Karl F ^b   Horvath, William ^a   Isaacson, Robert L ^a  

^a BINGHAMTON UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Aluminum; Amyloid; Cerebrovasculature; Chronic; Fluoride; Hippocam pus; Neocortex; Neurotoxicity; Rat

Indexed keywords

ALUMINUM FLUORIDE; AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; DRINKING WATER; FLUORIDE SODIUM; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN LEVEL; CONTROLLED STUDY; FLUORIDATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER LEVEL; LONG TERM EXPOSURE; MALE; NEOCORTEX; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SILVER STAINING; TISSUE LEVEL;

ALUMINUM COMPOUNDS; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; FLUORIDES; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; NEURONS; RATS; SERUM AMYLOID A PROTEIN; SODIUM FLUORIDE; TISSUE DISTRIBUTION;

EID: 0032536490     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01336-X     Document Type: Article

References (82)

1. Ahn H.W., Fulton B., Moxon D., Jeffery E.H. Interactive effects of fluoride and aluminum uptake and accumulation in bones of rabbits administered both agents in their drinking water. J. Toxicol. Environ. Health. 44:1995;337-350.
2. Aisen P.S., Davis K.L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry. 151:1994;1105-1113.
3. Armstrong R.A. Is the clustering of beta-amyloid (A beta) deposits in the frontal cortex of Alzheimer patients determined by blood vessels? Neurosci. Lett. 195:1995;121-124.
4. Armstrong R.A., Winsper S.J., Blair J.A. Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms. Dementia. 7:1996;1-9.
5. Augenstein W.L., Spoerke D.G., Kulig K.W., Hall A.H., Hall P.K., Riggs B.S., Saadi M.E., Rumack B.M. Fluoride ingestion in children: A review of 87 cases. Pediatrics. 88:1991;907-912.
6. Banks W.A., Kastin A.J. Aluminum alters the permeability of the blood-brain barrier to some non-peptides. Neuropharmacology. 24:1985;407-412.
7. Banks W.A., Maness L.M., Banks M.F., Kastin A.J. Aluminum-sensitive degradation of amyloid beta-protein 1-40 by murine and human intracellular enzymes. Neurotoxicol. Teratol. 18:1996;671-677.
8. E. Benjami, S. Leskowitz, Immunology: A Short Course, Wiley-Liss, New York, 1991.
9. Bluestein H.G., Zvaifler N.J. Antibodies reactive with central nervous system antigens. Hum. Pathol. 14:1983;424-428.
10. E. Braunwald, K.J. Isselbacher, R.G. Petersdorf, J.D. Wilson, J.B. Martin, A.S. Fauci, Harrison's Principles of Internal Medicine. McGraw-Hill, New York, 1987.
11. Buee L., Hof P.R., Bouras C., Delacourte A., Perl D.P., Morrison J.H., Fillit H.M. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 87:1994;469-480.
12. Chong Y.H., Suh Y.H. Aggregation of amyloid precursor proteins by aluminum in vitro. Brain Res. 670:1995;137-141.
13. Crapper D.R., Dalton A.J. Aluminum induced neurofibrillary degeneration, brain electrical activity, and alterations in acquisition and retention. Physiol. Behav. 10:1973;935-945.
14. De Boni U., Scott J.W., Crapper D.R. Intracellular aluminum binding: A histochemical study. Histochem. J. 40:1974;31-37.
15. De La Torre J.C. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Biobehav. Rev. 18:1994;397-407.
16. Domingo J.L. Adverse effects of aluminium-chelating compounds for clinical use. Adverse Drug React. Toxicol. Rev. 15:1996;145-165.
17. R.Y. Eagers, Toxic Properties of Inorganic Fluorine Compounds. Elsevier, Amsterdam, 1986.
18. Exley C. Amyloid, aluminum and the etiology of Alzheimer's disease. Med. J. Aust. 164:1996;252-253. letter; comment.
19. Exley C., Burgess E., Day J.P., Jeffery E.H., Melethil S., Yokel R.A. Aluminum toxicokinetics. J. Toxicol. Environ. Health. 48:1996;569-584.
20. Exley C., Price N.C., Kelly S.M., Birchall J.D. An interaction of beta-amyloid with aluminum in vitro. FEBS Lett. 324:1993;293-295.
21. Fasman G.D., Perczel A., Moore C.D. Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates. Proc. Natl. Acad. Sci. USA. 92:1995;369-371.
22. Fleming J., Joshi J.G. Ferritin: isolation of aluminum-ferritin complex from the brain. Proc. Natl. Acad. Sci. USA. 84:1987;7866-7870.
23. Forbes W.F., Hayward L.M., Agwani N. Dementia, aluminium, and fluoride. Lancet. 338:1991;1592-1593. letter; comment.
24. Forbes W.F., McLachlan D.R. Further thoughts on the aluminum-Alzheimer's disease link. J. Epidemiol. Community Health. 50:1996;401-403.
25. Fulton B., Jaw S., Jeffery E.H. Bioavailability of aluminum from drinking water. Fundam. Appl. Toxicol. 12:1989;144-150.
26. Gaytan-Garcia S., Kim H., Strong M.J. Spinal motor neuron neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament (NFH). Toxicology. 108:1996;17-24.
27. Gotow T., Tanaka J., Takeda M. The organization of neurofilaments accumulated in perikaryon following aluminum administration: relationship between structure and phosphorylation of neurofilaments. Neuroscience. 64:1995;553-569.
28. Hardy J.A. Anatomical cascade hypothesis for Alzheimer's disease. TINS. 15:1992;200-201.
29. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185.
30. Harris W.R., Berthon G., Day J.P., Exley C., Flaten T.P., Forbes W.F., Kiss T., Orvig C., Zatta P.F. Speciation of aluminum in biological systems. J. Toxicol. Environ. Health. 48:1996;543-568.
31. Hart M.N., Bennett-Gray J., Menezes A.H., Goeken J.A., Schelper R.L., Wisniewski H.M. Beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations. Am. J. Pathol. 132:1988;167-172.
32. Hassler O. Arterial deformities in senile brains. Acta Neuropathol. 8:1967;219-229.
33. Itzhaki R.F. Possible factors in the etiology of Alzheimer's disease. Mol. Neurobiol. 9:1994;1-13.
34. Jacqmin M., Commenges D., Letenneur L., Barberger-Gateau P., Dartigues J.F. Components of drinking water and risk of cognitive impairment in the elderly. Am. J. Epidemiol. 139:1994;48-57.
35. Johnson G.V.W., Jope R.S. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res. 403:1987;1-6.
36. Kalaria R.N., Pax A.B. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res. 705:1995;349-352.
37. Kalaria R.N., Premkumar D.R.D., Pax A.B., Cohen D.L., Lieberburg I. Production and increased detection of amyloid B protein and amyloidogenic fragments in brain microvessels, meningeal vessels, and choroid plexus in Alzheimer's disease. Brain Res. Mol. Brain Res. 35:1996;58-68.
38. Kaminsky L.S., Moheny M.C., Leach J., Melius J., Miller M.J. Fluoride: benefits and risks of exposure. Crit. Rev. Oral Biol. Med. 1:1990;261-281.
39. Kanaho Y., Moss J., Vaughn M. Mechanism of inhibitors of transducin GTPase activity by fluoride and aluminum. J. Biol. Chem. 260:1985;11493-11497.
40. Kawahara M., Muramoto K., Kobayashi K., Mori H., Kuroda Y. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem. Biophys. Res. Commun. 198:1994;531-535.
41. Kiamoto T., Ogomori K., Tateishi J., Prusiner S.B. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57:1987;230-236.
42. Kraus A.S., Forbes W.F. Aluminum, fluoride and the prevention of Alzheimer's disease. Can. J. Public Health. 83:1992;97-100.
43. Kuroda Y., Kawahara M. Aggregation of amyloid beta-protein and its neurotoxicity: enhancement by aluminum and other metals. Tohoku. J. Exp. Med. 174:1994;263-268.
44. L.R. McDowell, Minerals in Animal and Human Nutrition. Academic Press, San Diego, 1992.
45. McGeer P.L., McGeer E.G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
46. McIvor M.E. Acute fluoride toxicity. Drug Safety. 5:1997;79-85.
47. McLachlan D.R., Bergeron C., Smith J.E., Boomer D., Rifat S.L. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 46:1996;401-405. See comments.
48. D.R. McLachlan, J. Massiah, Aluminum ingestion: a risk factor for Alzheimer's disease, in: R.L. Isaacson, K.F. Jensen (Eds.), The Vulnerable Brain and Environmental Risks: Toxins in Food, Vol. 2. Plenum, New York, 1992, pp. 49-50.
49. Morris C.M., Keith A.B., Edwardson J.A., Pullen R.G.L. Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59:1992;300-305.
50. Mundy W.R., Freudenrich T., Shafer T.J., Nostrandt A.C. In vitro aluminum inhibition of brain phosphoinositide metabolism: comparison of neonatal and adult rats. Neurotoxicology. 16:1995;35-44.
51. Mundy W.R., Kodavanti P.R., Dulchinos V.F., Tilson H.A. Aluminum alters calcium transport in plasma membrane and endoplasmic reticulum from rat brain. J. Biochem. Toxicol. 9:1994;17-23.
52. Neri L.C., Hewitt D. Aluminum, Alzheimer's disease, and drinking water. Lancet. 338:1991;390.
53. Nixon R.A., Clarke J.F., Logvinenko K.B., Tan M.K., Hoult M., Grynspan F. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes. J. Neurochem. 55:1990;1950-1959.
54. Nostrandt A.C., Shafer T.J., Mundy W.R., Padilla S. Inhibition of rat brain phosphatidylinositol-specific phospholipase C by aluminum: regional differences, interactions with aluminum salts, and mechanisms. Toxicol. Appl. Pharmacol. 136:1996;118-125.
55. Paik S.R., Lee J.H., Kim D.H., Chang C.S., Kim J. Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid. Arch. Biochem. Biophys. 344:1997;325-334.
56. Paranjpe M.G., Chandra A.M., Qualls C.W. Jr., McMurry S.T., Rohrer M.D., Whaley M.M., Lochmiller R.L., McBee K. Fluorosis in a wild cotton rat (Sigmodon hispidus) population inhabiting a petrochemical waste site. Toxicol. Pathol. 22:1994;569-578.
57. Roses A.D. Apolipoprotein E affects the rate of Alzheimer's disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:1994;429-437.
58. Roskams A.J., Connor J.R. Aluminum access to the brain: A role for transferrin and its receptor. Proc. Natl. Acad. Sci. USA. 87:1990;9024-9027.
59. E.M. Ross, G-proteins and receptors in neuronal signalling, in: Z.W. Hall (Ed.), An Introduction to Molecular Neurobiology. Sinauer Assoc., MA, 1992, pp. 181-206.
60. Salib E., Hillier V. A case-control study of Alzheimer's disease and aluminium occupation. Br. J. Psychiatry. 168:1996;244-249.
61. Schroeder J.C., Tolbert P.E., Eisen E.A., Monson R.R., Hallock M.F., Smith T.J., Woskie S.R., Hammond S.K., Milton D.K. Mortality studies of machining fluid exposure in the automobile industry: IV. A case-control study of lung cancer. Am. J. Ind. Med. 31:1997;525-533.
62. Selkoe D.J. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. TINS. 16:1993;403-409.
63. Selkoe D.J. Alzheimer's disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53:1994;438-447.
64. Shafer T.J., Mundy W.R. Effects of aluminum on neuronal signal transduction: mechanisms underlying disruption of phosphoinositide hydrolysis. Gen. Pharmacol. 26:1995;889-895.
65. Shea T.B. Calcium modulates aluminum neurotoxicity and interaction with neurofilaments. Mol. Chem. Neuropathol. 24:1995;151-163.
66. Shea T.B., Husain T. Inhibition of proteolysis enhances aluminum-induced perikaryal neurofilament accumulation but does not enhance tau accumulation. Mol. Chem. Neuropathol. 26:1995;195-212.
67. Shigematsu K., McGeer P.L. Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts. Brain Res. 593:1992;117-123.
68. Shupe J.L., Bruner R.H., Seymour J.L., Alden C.L. The pathology of chronic bovine fluorosis: A review. Toxicol. Pathol. 20:1992;274-288.
69. Spittle B. Psychopharmacology of fluoride: A review. Int. Clin. Psychopharmacol. 9:1994;79-82.
70. Sternweis P.C., Gilman A.G. Aluminum: A requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc. Natl. Acad. Sci. USA. 79:1982;4888-4891.
71. Still C.N. Aluminum neurotoxicity and Alzheimer's disease. J.S.C. Med. Assoc. 90:1994;560-564.
72. Storey E., Masters C.L. Amyloid, aluminium and the etiology of Alzheimer's disease. Med. J. Aust. 163:1995;256-259.
73. Strong M.J. Aluminum neurotoxicity: An experimental approach to the induction of neurofilamentous inclusions. J. Neurol. Sci. 124:1994;20-26. Suppl.
74. Strong M.J., Mao K., Nerurkar V.R., Wakayama I., Yanagihara R., Garruto R.M. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity. Mol. Cell Neurosci. 5:1994;319-326.
75. Taylor G.A., Newens A.J., Edwardson J.A., Kay D.W., Forster D.P. Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England. J. Epidemiol. Community Health. 49:1995;323-324. See comments.
76. Trimmer E. Aluminium and Alzheimer's disease in Finchley, north London. Lancet. 344:1994;486. letter; comment.
77. Varner J.A., Horvath W.J., Huie C.W., Naslund H.R., Isaacson R.L. Chronic aluminum fluoride administration: I. Behavioral observations. Behav. Neural Biol. 61:1994;233-241.
78. 3 administration: II. Selected histological observations. Neurosci. Res. Comm. 13:1993;99-104.
79. Wakayama I., Nerurkar V.R., Strong M.J., Garruto R.M. Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of amyotrophic lateral sclerosis. Acta Neuropathol. 92:1996;545-554.
80. Walton J.R. Amyloid, aluminium and the etiology of Alzheimer's disease. Med. J. Aust. 164:1996;382-383.
81. Whitford G.M. Acute and chronic fluoride toxicity. J. Dent. Res. 71:1992;1249-1254.
82. Wu N., Horvath W.J., Huie C.W. Speciation of inorganic aluminum using capillary zone electrophoresis with indirect UV detection. J. Chromatogr. 635:1993;307-312.